Paper18480205
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.
Mayer SA and 8 others. N Engl J Med, 2008. Cited by 943 papers, by iCite.
Cite this record
ConductScience Library. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. Papers, record 18480205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18480205
- Disease
- intracerebral hemorrhage65 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cerebral Hemorrhage | Major topic |
| Factor VIIa | Major topic |
| Hematoma | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Double-Blind Method | |
| Female | |
| Glasgow Coma Scale | |
| Humans | |
| Kaplan-Meier Estimate | |
| Male | |
| Middle Aged | |
| Recombinant Proteins | |
| Tomography, X-Ray Computed | |
| Treatment Failure |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00127283 | Recombinant Factor VIIa in Acute Intracerebral Haemorrhage | Results | Yes | ClinicalTrials.gov |
| NCT01202864 | Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) | Background | ClinicalTrials.gov | |
| NCT04200781 | Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke | Results | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 18480212 | Intracerebral hemorrhage--improving outcome by reducing volume? | https://conductscience.org/library/papers/18480212 |
Source PubMed
Cited by405
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 943 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42769054 | A decision tree model for hematoma expansion prediction in women after spontaneous intracerebral hemorrhage. | Front Neurol | 2026 | https://conductscience.org/library/papers/42769054 | PubMed |
| 42602263 | Tranexamic acid for neurological outcomes and mortality in adults with hemorrhagic acute brain injury: an updated systematic review and meta-analysis of randomized controlled trials. | Front Neurol | 2026 | https://conductscience.org/library/papers/42602263 | PubMed |
| 42539564 | Attenuation value of non-contrast computed tomography for spontaneous intracerebral hemorrhage: an important marker for the rapid identification of hematoma expansion. | Front Neurol | 2026 | https://conductscience.org/library/papers/42539564 | PubMed |
| 42477258 | Effect on Mortality of Anticoagulant Reversal in Acute Intracranial Hemorrhage: A Systematic Review and Meta-analysis. | Neurocrit Care | 2026 | https://conductscience.org/library/papers/42477258 | PubMed |
| 42443603 | Evolution of randomized controlled trials in adult neurosurgical critical care from 1990 to 2024 in the United States. | Neurosurg Rev | 2026 | https://conductscience.org/library/papers/42443603 | PubMed |
| 42318415 | Research on predicting risk factors for re-bleeding in the acute phase of intracerebral hemorrhage using machine learning algorithms. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42318415 | PubMed |
| 42294608 | Two Decades of Therapeutic Trials in Supratentorial Intracerebral Haemorrhage: Lessons from Failure and Success. | Expert Rev Mol Med | 2026 | https://conductscience.org/library/papers/42294608 | PubMed |
| 42027301 | Therapeutic strategies in intracerebral hemorrhage: from hematoma stabilization to alleviating secondary brain injury. | Res Pract Thromb Haemost | 2026 | https://conductscience.org/library/papers/42027301 | PubMed |
| 41815808 | Advances in intracerebral hemorrhage management: A comprehensive review. | Brain Circ | 2026 | https://conductscience.org/library/papers/41815808 | PubMed |
| 41696748 | Ultra-early follow-up computed tomography detects hematoma expansion in intracerebral hemorrhage with high accuracy. | Front Neurol | 2025 | https://conductscience.org/library/papers/41696748 | PubMed |
| 41614513 | Influence of spot sign on the association between rapidly achieving blood pressure reduction and intracerebral haemorrhage outcomes. | Eur Stroke J | 2026 | https://conductscience.org/library/papers/41614513 | PubMed |
| 41614507 | Ultra-early computed tomography markers of haematoma expansion: Potential trial targets? | Eur Stroke J | 2026 | https://conductscience.org/library/papers/41614507 | PubMed |
| 41593741 | Outcomes of combined carbazochrome sodium sulfonate plus tranexamic acid therapy versus tranexamic acid monotherapy in traumatic brain injury: a retrospective cohort study in Japan. | J Intensive Care | 2026 | https://conductscience.org/library/papers/41593741 | PubMed |
| 41573015 | Postoperative Rebleeding: The Sword of Damocles in Minimally Invasive Surgery for Intracerebral Hemorrhage. | Research (Wash D C) | 2026 | https://conductscience.org/library/papers/41573015 | PubMed |
| 41532529 | Location-Specific Analysis of Hematoma Expansion in Intracerebral Hemorrhage. | J Am Heart Assoc | 2026 | https://conductscience.org/library/papers/41532529 | PubMed |
| 41284785 | Every Minute Counts: A Paradigm Shift in ICH: Perspectives and Recommendations From the Fourth Hemorrhagic Stroke Academia Industry (HEADS) Roundtable. | Stroke | 2025 | https://conductscience.org/library/papers/41284785 | PubMed |
| 41245927 | The Impact of Intervention Modality on Mortality Outcomes in Patients With Hemorrhagic Strokes: A Meta-Analysis. | Cureus | 2025 | https://conductscience.org/library/papers/41245927 | PubMed |
| 41159140 | Intracerebral Hemorrhage: Advances, Knowledge Gaps, and Future Directions. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/41159140 | PubMed |
| 41088400 | Targeted lipid nanoparticles containing IL-10 mRNA improve outcomes in experimental intracerebral hemorrhage. | J Neuroinflammation | 2025 | https://conductscience.org/library/papers/41088400 | PubMed |
| 41010684 | Early Hematoma Evacuation Can Prevent Infectious Complications in Patients with Spontaneous Intracerebral Hemorrhage. | J Clin Med | 2025 | https://conductscience.org/library/papers/41010684 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| EPTACOG ALFA (ACTIVATED) | CHEMBL2108334 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL2108334 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18480205
GET https://conductscience.org/api/papers/v1/18480205/cited_by?page=2